Calamos Advisors
BSTC

Calamos Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Calamos Advisors’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-9,456
Closed -$334K – 700
2014
Q3 		$334K Hold
9,456
– – ﹤0.01% 620
2014
Q2 		$255K Buy
9,456
+1,404
+17% +$36.6K ﹤0.01% 629
2014
Q1 		$209K Buy
+8,052
New +$193K ﹤0.01% 615

Other funds holding BSTC

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Calamos Advisors's BSTC Position: Q4 2014 in Review

Calamos Advisors sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2014, closing a stake of 9,456 shares — an estimated $334K sold.

Calamos Advisors first reported a position in BSTC in Q1 2014 and held it in 3 quarters. The position peaked at $334K in Q3 2014. 85 funds tracked by Wall St. Rank hold BSTC as of Q4 2014.

  • Calamos Advisors reported no remaining BioSpecifics Technologies Corp. position as of Q4 2014 after selling out during the quarter.
  • Calamos Advisors sold 9,456 BioSpecifics Technologies Corp. shares in Q4 2014, an estimated $334K.
  • Calamos Advisors first reported a position in BioSpecifics Technologies Corp. in Q1 2014 and held it in 3 quarters.
  • Calamos Advisors's BioSpecifics Technologies Corp. position peaked at $334K in Q3 2014.
  • 85 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2014.

Based on Calamos Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.